Department of Pathophysiology, Key Laboratory of Cardiovascular Disease and Molecular Intervention, Nanjing Medical University, Nanjing 211166, People's Republic of China.
Department of Pathophysiology, Key Laboratory of Cardiovascular Disease and Molecular Intervention, Nanjing Medical University, Nanjing 211166, People's Republic of China.
Biochem Pharmacol. 2019 Oct;168:392-403. doi: 10.1016/j.bcp.2019.07.027. Epub 2019 Aug 2.
Macrophage class A1 scavenger receptor (SR-A1) is a pattern recognition receptor with an anti-inflammatory feature in cardiovascular diseases. However, its role in acute aortic dissection (AD) is not known yet. Using an aortic dissection model in SR-A1-deficient mice and their wild type littermates, we found that SR-A1 deficiency aggravated beta-aminopropionitrile monofumarate induced thoracic aortic dilation, false lumen formation, extracellular matrix degradation, vascular inflammation and accumulation of apoptotic cells. These pathological changes were associated with an impaired macrophage efferocytosis mediated by tyrosine-protein kinase receptor Tyro3 in vitro and in vivo. SR-A1 could directly interact with Tyro3 and was required for Tyro3 phosphorylation to activate its downstream PI3K/Akt signaling pathway. Importantly, co-culture of SR-A1 macrophages with apoptotic Jurkat cells resulted in less devoured apoptotic cells accompanied by swelling mitochondria and damaged ATP generation, following poor IL-10 and robust TNF-α production. Deficiency of SR-A1 did not influence phagolysosome formation during the efferocytosis. Lentiviral overexpression of Tyro3 in SR-A1 macrophages induced restorative phagocytosis in vitro. Administration of Tyro3 agonist protein S could restore SR-A1 macrophages phagocytosis in vitro and in vivo. These findings suggest that SR-A1-Tyro3 axis in macrophages mitigate AD damage by promoting efferocytosis and inhibiting inflammation.
巨噬细胞 A 类清道夫受体(SR-A1)是一种模式识别受体,在心血管疾病中具有抗炎特性。然而,其在急性主动脉夹层(AD)中的作用尚不清楚。我们使用 SR-A1 缺陷小鼠及其野生型同窝仔鼠的主动脉夹层模型发现,SR-A1 缺乏加重了β-氨基丙腈单富马酸盐诱导的胸主动脉扩张、假腔形成、细胞外基质降解、血管炎症和凋亡细胞的积累。这些病理变化与体外和体内酪氨酸蛋白激酶受体 Tyro3 介导的巨噬细胞吞噬作用受损有关。SR-A1 可以直接与 Tyro3 相互作用,并需要 Tyro3 磷酸化来激活其下游的 PI3K/Akt 信号通路。重要的是,SR-A1 巨噬细胞与凋亡 Jurkat 细胞共培养后,伴随着肿胀的线粒体和受损的 ATP 生成,吞噬的凋亡细胞减少,IL-10 产生减少,TNF-α 产生增加。吞噬作用过程中,SR-A1 缺乏并不影响吞噬溶酶体的形成。SR-A1 巨噬细胞中 Tyro3 的慢病毒过表达在体外诱导了恢复性吞噬作用。Tyro3 激动剂蛋白 S 的给药可以恢复 SR-A1 巨噬细胞的体外和体内吞噬作用。这些发现表明,巨噬细胞中的 SR-A1-Tyro3 轴通过促进吞噬作用和抑制炎症来减轻 AD 损伤。
Biochem Pharmacol. 2019-8-2
Biochem Pharmacol. 2023-7
Biochem Pharmacol. 2014-5-27
Emerg Microbes Infect. 2021-12
J Cardiothorac Surg. 2024-10-1
Rev Cardiovasc Med. 2023-11-30
Front Immunol. 2024